Abstracts (HTML) List of Authors

Wahl, G

Dental health needs assessment and treatment in patients awaiting liver transplant

Waisman, A

Hepatic IL-1 signaling in NAFLD is a driver of whole-body insulin resistance and adipose tissue inflammation.

Wan, S

Hippo pathway effectors YAP and TAZ are opponents in the regulation of hepatic fibrosis

Wandrer, F

Activin-driven fate determination is pivotal for liver progenitor cells to take over hepatocytic function in in ACLF

Wang, B

Der angiokrine HGF-Signalweg steuert die Organ- und Körpergröße sowie die Hepatozytenproliferation
Hepatic activation of FOXO3 regulates mTORC2-Akt and enhances oxidative damage-associated hepatocellular carcinogenesis

Wang, J

Influence on hepatocellular carcinoma energy metabolism by pharmacological inhibition of the epigenetic modifier LSD1

Wang, L

Influence on hepatocellular carcinoma energy metabolism by pharmacological inhibition of the epigenetic modifier LSD1

Wang, S

FOXA2 replaces FXR to maintain BSEP expression on bile canaliculi in acute-on-chronic liver failure
FOXA2 replaces FXR to maintain BSEP expression on bile canaliculi in acute-on-chronic liver failure
Hepatic iron overload in alcoholic liver disease: The role of sinusoidal endothelial cells in iron sensing
Role of NOX1 on hepcidin signaling in the crosstalk between macrophages and hepatocytes
Activin-driven fate determination is pivotal for liver progenitor cells to take over hepatocytic function in in ACLF

Wang, Y

Hepatic activation of FOXO3 regulates mTORC2-Akt and enhances oxidative damage-associated hepatocellular carcinogenesis

Weber, A

Antioxidant-based therapy in non-alcoholic steatohepatitis (NASH) and NASH-induced hepatocellular carcinoma development
A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control
Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC

Weber, S

Genes involved in hepatic cholesterol homeostasis identified as modifiers of cholestasis in Abcb4 deficient mice
Common genetic variant c.711A>T in the hepatobiliary phospholipid translocator ABCB4 as risk factor for liver fibrosis

Weber, SN

Abcg8 19 H Variante im Mausmodell: Größere Gallenblasenvolumina und gesteigerte biliäre Sterolkonzentrationen
Fibroblast growth factor 21 response in a preclinical alcohol model of acute-on-chronic liver injury
Il-2, Il-22 and Rantes upregulation in a new mouse model of bacterial infection related acute-on-chronic liver injury

Wedemeyer, H

Long-term course of a patient with overlap hepatitis C and IgG4-related cholangitis
Soluble inflammatory molecules do not completely normalize despite early treatment of acute symptomatic hepatitis C
Slow progressive very late-onset LAL-D: the importance of liver biopsy
Hepatic steatosis in Crohn's disease: associations with anti-TNFα treatment, dysbiosis, and FGF-19.
Cirrhosis and acute-on-chronic liver failure are linked with aberrant expression of co-stimulatory markers on T-cells
Hippo signaling counter regulates early innate immunity in hepatocytes exposed to Hepatitis B virus
NK cells regulate LSEC to promote the HBV-specific T cells response
Safety and Efficacy of 10 mg Myrcludex B/IFNa Combination Therapy in Patients with Chronic HBV/HDV Co-Infection

Wege, H

Real-life efficacy and safety profile of TACE in patients with intermediate HCC in a large German cohort
Retrospective evaluation of RFA and MWA for the treatment of HCC at the University Medical Center Hamburg 2008 – 2016
Improvement in median OS in patients with advanced HCC and strict eligibility criteria receiving Sorafenib

Wehr, K

NEMO prevents hepatocarcinogenesis independently of an IKK complex function by controlling liver regeneration

Wei, T

YAP-induced tumor initiation mediates a switch in hepatic macrophage identity via the Ccl2/Ccr2 axis

Weidemann, S

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities
Aberrant expression of activation regulators CBL-B, CTLA-4 and PD-1 in intrahepatic Teff cells in autoimmune hepatitis
Autoimmune hepatitis in mice is enabled by insufficient deletion of autoreactive CD4 T cells and plasticity of Tregs
Pyruvate kinase M2-deficiency in T cells leads to exacerbation of ConA hepatitis and alterations of T cell polarization

Weigel, S

Non-malignant portal vein thrombosis in liver cirrhosis – predictors of risk and the use of anticoagulation

Weigert, A

Cirrhosis and acute-on-chronic liver failure are linked with aberrant expression of co-stimulatory markers on T-cells

Weiler, S

The TAZ target gene ITGAV regulates invasion and positively feedbacks on YAP and TAZ in liver cancer cells
YAP-induced tumor initiation mediates a switch in hepatic macrophage identity via the Ccl2/Ccr2 axis

Weiler, SME

Hippo pathway effectors YAP and TAZ are opponents in the regulation of hepatic fibrosis
Dysregulation of Hippo/Yap signaling induces chromosome instability in intrahepatic cholangiocarcinoma

Weiler-Normann, C

Autoimmune hepatitis in mice is enabled by insufficient deletion of autoreactive CD4 T cells and plasticity of Tregs

Weiner, A

Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC

Weinmann, A

Extending the reach of the ALBI score for primary hepatic malignancies: Does ALBI work for cholangiocarcinoma?
Survival prediction for patients with ICC undergoing chemotherapy: comparing tumor markers to cross-sectional imaging
Distant metastases in patients with intrahepatic cholangiocarcinoma: Does location matter?
Non-malignant portal vein thrombosis in liver cirrhosis – predictors of risk and the use of anticoagulation
HILPDA is upregulated, predicts prognosis and promotes cancer progression in hepatocellular carcinoma
TGFβ-activated kinase 1 (TAK1) is activated and predicts prognosis in hepatocellular carcinoma

Weinmann-Menke, J

Extrakorporale Leberunterstützung mit ADVOS in Patienten mit ACLV und HRS – Erste Ergebnisse einer Single Center Studie

Weiskirchen, R

Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatic Fibrosis

Weiss, AC

Growth differentiation factor 11 mitigates liver fibrosis via expansion of liver progenitor cells

Weiss, KH

HER2 amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
An umbrella concept for patients with advanced intrahepatic cholangiocarcinoma
Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis

Weiss, TS

Evaluation of a piglet model for Parenteral Nutrition-associated Cholestasis (PNAC)
Augmenter of Liver Regeneration (ALR) reduziert die Gallensäure induzierte Apoptose

Welsch, C

Cirrhosis and acute-on-chronic liver failure are linked with aberrant expression of co-stimulatory markers on T-cells
Systemic inflammation is associated with hyperdynamic circulation and predicts acute-on-chronic liver failure

Weng, H

FOXA2 replaces FXR to maintain BSEP expression on bile canaliculi in acute-on-chronic liver failure
Activin-driven fate determination is pivotal for liver progenitor cells to take over hepatocytic function in in ACLF

Wenzel, J

In-vitro Activation and anti-viral Function of Innate NK cells in HEV Infection

Werge, MP

Systemic inflammation is associated with hyperdynamic circulation and predicts acute-on-chronic liver failure

Werner, J

Evaluation of a piglet model for Parenteral Nutrition-associated Cholestasis (PNAC)
Lipid-loaded Hepatocytes fail to Suppress IL-4 Production by Human CD4+ iNKT Cells
In-vitro Activation and anti-viral Function of Innate NK cells in HEV Infection

Werner, K

Hedgehog Signaling as a mediator between liver and adipose tissue

Werner, T

Real-life efficacy and safety profile of TACE in patients with intermediate HCC in a large German cohort
Retrospective evaluation of RFA and MWA for the treatment of HCC at the University Medical Center Hamburg 2008 – 2016
Improvement in median OS in patients with advanced HCC and strict eligibility criteria receiving Sorafenib

Wettengel, J

Oxygenation and miR138-5 p act as rheostats in APOBEC3B-mediated Hepatitis B Virus control

Wherry, EJ

TOX expression on HBV specific CD8+ T cells is linked to clinical stage of chronic HBV infection

Wiegand, J

PNPLA3 and HSD17B13 gene variants exert opposite effects on fatty liver phenotypes: results from the FLAG cohort

Wieland, D

Persistence of a transcriptional chronic scar on HCV-specific CD8+ T cells after DAA-mediated antigen removal
TOX expression on HBV specific CD8+ T cells is linked to clinical stage of chronic HBV infection

Wieschendorf, B

Activation of the arylhydrocarbon receptor sensitizes to acetaminophen-induced acute liver failure

Wiesner, O

Dimethyl fumarate (DMF) inhibits migration and proliferation of hepatocellular carcinoma (HCC)

Wildgruber, M

Predictive parameters and effectiveness of TIPS reduction in treatment of hepatic encephalopathy after TIPS

Will, U

Antibiotische Therapie von Leberabszessen: Enterokokken sind eine häufige Ursache für ein Therapieversagen

Willuweit, K

Long-term course of a patient with overlap hepatitis C and IgG4-related cholangitis

Wimmer, R

Hydrophobe Gallensäuren wirken durch PI3K-abhängige Proliferation von Sternzellen pro-fibrotisch

Wingerath, J

Transcriptional profiling of tumor-specific CD8 T cells shows contribution of TIGIT to T cell exhaustion in liver cancer

Winkler, F

Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis

Wirth, T

Hepatic activation of FOXO3 regulates mTORC2-Akt and enhances oxidative damage-associated hepatocellular carcinogenesis

Wirth, TC

Transcriptional profiling of tumor-specific CD8 T cells shows contribution of TIGIT to T cell exhaustion in liver cancer

Wirtz, T

Extracellular vesicles from steatotic hepatocytes influence stellate cells in liver fibrosis

Wirtz, TH

Macrophage Migration Inhibitory Factor promotes HCC progression in vivo via the receptor CD74

Wisplinghoff, H

Phenotyping non-alcoholic fatty liver disease by the gut microbiota – ready for prime time?

Witte, V

Real-world efficacy of EBR/GZR in HCV GT1 patients with multiple comorbidities and medications: results from the DHC-R
Real-world efficacy of elbasvir/grazoprevir in HCV GT1 infected diabetics: results from the German Hepatitis C Registry

Witzel, HR

Lipid droplet proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3
HILPDA is upregulated, predicts prognosis and promotes cancer progression in hepatocellular carcinoma
TGFβ-activated kinase 1 (TAK1) is activated and predicts prognosis in hepatocellular carcinoma

Woditsch, V

Europäische Studie: Heterozygoter Alpha-1-Antitrypsinmangel (Pi*MZ) führt zu einem intermediären Leber-Phänotyp
Metabolische Veränderungen bei Erwachsenen mit homozygotem Alpha1-Antitrypsinmangel (Pi*ZZ Genotyp)

Wohlleber, D

A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control
Development of liver-resident CD8 T cells during persistent viral liver infection results in functional adaptation

Woitok, MM

Shedding light on BASH: A novel experimental model of advanced liver damage
The role of ferroptosis in chronic liver disease

Wolf, K

A novel receptor for bile salts – the G protein-coupled receptor MRGX4 is expressed on sensory neurons

Wolf, S

Hepatocytes modify macrophage polarization by reducing the availability of active TGFβ

Wolff, K

RAGE signaling in liver progenitor cells affects fibrosis upon liver injury

Wölfl, S

Smad3 linker (S213 and S204) phosphorylation as indicators for the prediction of cholangiocarcinoma outcome

Woller, N

Transcriptional profiling of tumor-specific CD8 T cells shows contribution of TIGIT to T cell exhaustion in liver cancer

Wörns, M

Cancer stem cells as significant drivers of sorafenib resistance in hepatocellular carcinoma

Wörns, MA

Hepatic IL-1 signaling in NAFLD is a driver of whole-body insulin resistance and adipose tissue inflammation.
Epidemiologie und Auswirkungen bakterieller Infektionen bei stationären Patienten mit Leberzirrhose
Vitamin A deficiency is associated with disease severity in patients with liver cirrhosis
Symptom burden and treatment response in patients with primary biliary cholangitis (PBC)
Outcome prediction of covert hepatic encephalopathy in liver cirrhosis: comparison of four testing strategies
Non-malignant portal vein thrombosis in liver cirrhosis – predictors of risk and the use of anticoagulation
SEAL program – Early detection of liver fibrosis and cirrhosis by screening of the general population

Wöstemeier, A

Aberrant expression of activation regulators CBL-B, CTLA-4 and PD-1 in intrahepatic Teff cells in autoimmune hepatitis

Wu, J

NK cells regulate LSEC to promote the HBV-specific T cells response